Clinical Trial Detail

NCT ID NCT02956798
Title Pazopanib Vs. Local Therapy for Renal Cancer With Metastases
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications

renal cell carcinoma

Therapies

Pazopanib

Age Groups: senior adult

No variant requirements are available.